Medicilon was honored as "2023 Growth Potential Company"A Story by Medicilon
On June 12, 2023, the list of "18th China Listed Companies Competitive Credibility Company" organized by Chinese Securities Journal was announced. Shanghai Medicilon Inc. (Medicilon) was awarded the "2023 Growth Potential Company" by virtue of its stable and excellent profitability, innovation ability, and competitive strength. © 2023 Medicilon |
Stats
27 Views
Added on June 25, 2023 Last Updated on June 25, 2023 Author
MedicilonCambridge, MAAboutMedicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D services for pharmaceutical enterprises and scientific research institutions around the w.. more..Writing
|
Share This
Email
Facebook
Twitter
Read Request
My Library
Subscribe
Flag Writing
